Nuclera
Nuclera’s mission is to accelerate discovery by providing researchers rapid, easy access to the highest-quality functional proteins essential for drug discovery research. The Company’s eProtein Discovery™ benchtop system combines unique cell-free expression systems, novel digital microfluidics, and robust screening data to empower scientists to perform multiplex protein screening, characterization, and small-scale expression in-house.
By providing clear guidance on which protein has the best chance of success from the start, eProtein Discovery™ reduces the time, cost, and uncertainty traditionally associated with protein expression and purification. Researchers can generate soluble, purified proteins, including challenging membrane proteins, for downstream functional testing in under 48 hours, significantly accelerating workflows compared with months-long cell-based methods.
Founded in 2013, Nuclera has offices in Cambridge (UK) and Boston (US).
